IP Library › Granted Patent US 10,053,708
Granted Patent B2
US 10,053,708 · App. 15/309,995 · Granted Aug 21, 2018

TCR(alpha)-LCR-derived gene regulatory cassettes

Inventors: Benjamin D. Ortiz (New York, NY); Armin Lahiji (New York, NY)
Assignee: Research Foundation of the City University of New York
C12N15/85C07K14/7051C12N2740/15043C12N2830/46
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,053,708
App. No.
15/309,995
Granted
Aug 21, 2018
Kind
B2
Abstract

A method of delivering a transgene to a cell is provided. The method uses a vector that contains a T-cell receptor alpha locus control region (TCRαLCR) derived gene regulatory cassette having fewer than 5.0-kb. The method delivers the transgene with spatiotemporally specific gene expression and silencing-prevention controls to a cell such that a predetermined subset of progeny cell-types express a gene product from the transgene. Other progeny of the cell diminish, or silence, the expression of the gene product.

Claims (20)

1. A method of delivering a gene to a cell such that progeny of the cell expresses a predetermined gene product with spatiotemporal specificity and resistance to silencing, the method comprising:

introducing, in an in vitro environment, a vector to a cell, the vector comprising:

(a) a T-cell receptor alpha locus control region (TCRaLCR) derived gene regulatory cassette having fewer than 5.0-kb nucleotides, the TCRaLCR derived gene regulatory cassette comprising a sequence that is SEQ. ID NO: 1 and

(b) a first transgene to be expressed.

2. The method as recited in claim 1 , wherein the cell is a stem cell.

3. The method as recited in claim 1 , wherein the cell is a multi-potent precursor cell.

4. The method as recited in claim 3 , further comprising permitting the multi-potent precursor cell to proliferate and differentiate to form a population of T-cells and a population of non-T-cell progeny cells, wherein the population of T-cells differentiating from the multi-potent precursor cell expresses the first transgene with a first degree of expression and the population of non-T-cell progeny cells expresses the first transgene with a second degree of expression that is lower than the first degree of expression.

5. The method as recited in claim 4 , wherein the second degree of expression is zero.

6. The method as recited in claim 1 , wherein the first transgene is directly linked 5′ to the TCRαLCR derived gene regulatory cassette.

7. The method as recited in claim 1 , wherein the first transgene is directly linked 3′ to the TCRαLCR derived gene regulatory cassette.

8. The method as recited in claim 1 , wherein the first transgene is promoter-driven cDNA.

9. The method as recited in claim 1 , wherein the vector further comprises a second transgene, wherein first transgene and the second transgene flank the T-cell receptor alpha locus control region (TCRαLCR) derived gene regulatory cassette.

10. The method as recited in claim 1 , wherein the vector further comprises a second transgene and the second transgene is a promoter-driven cDNA.

11. The method as recited in claim 1 , wherein the vector consists of the T-cell receptor alpha locus control region (TCRaLCR) derived gene regulatory cassette and the first transgene.

12. The method as recited in claim 1 , wherein the vector consists of the T-cell receptor alpha locus control region (TCRaLCR) derived gene regulatory cassette and the first transgene and a second transgene.

13. A vector for delivering a gene to a cell such that progeny of the cell expresses a predetermined gene product with spatiotemporal specificity and resistance to silencing, the vector comprising:

(a) a T-cell receptor alpha locus control region (TCRaLCR) derived gene regulatory cassette having fewer than 5.0-kb nucleotides, the TCRaLCR derived gene regulatory cassette comprising, a sequence that is SEQ ID NO: 1 and

(b) a first transgene to be expressed.

14. The vector as recited in claim 13 , wherein the vector further comprises a second transgene, wherein first transgene and the second transgene flank the T-cell receptor alpha locus control region (TCRαLCR) derived gene regulatory cassette.

15. The vector as recited in claim 13 , wherein the vector further comprises a second transgene and the second transgene is a promoter-driven cDNA.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2016
From: ORTIZ, BENJAMIN D.; LAHIJI, ARMIN
To: RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK
Reel/Frame 040319/0629 →
Continuity (2)
Provisional Application 61990807 · May 9, 2014
Related Publication 20170240918A1 · Aug 24, 2017